Cytomedix, Inc. , a leading developer of biologically active regenerative therapies, today reported financial results for the three and twelve months ended December 31, 2012.
http://www.biospace.com/news_story.aspx?StoryID=290938&full=1
http://www.biospace.com/news_story.aspx?StoryID=290938&full=1
No comments:
Post a Comment